UK chemical sector growth, including pharmaceuticals, is forecast
at 3.6 per cent for 2004, outperforming the 2.3 per cent growth
estimated for Europe as a whole, according to a study presented at
the Chemical Industry Association's...
Sanofi's hostile bid for larger French rival Aventis may have been
rejected, but there are a number of arguments in favour of a link,
according to analyst Nicole Lamble at market research firm
Agilent Technologies has launched a software package to help drug
companies keep a close eye on the quality of chemical compounds.
The firm says the product is the first of its kind, allowing a more
than seven-fold increase in the...
A rheumatoid arthritis drug developed by Franco-German company
Aventis has been linked to the deaths of five patients in Japan,
prompting the company to warn against prescribing the drug to
people with respiratory problems.
A small US company has developed an encapsulation technology for
pharmaceuticals that promises to overcome a major healthcare
problem - deaths and illness caused by aspirin and other
non-steroidal anti-inflammatory drugs (NSAIDs).
A new metal detector capable of picking up ferrous and stainless
steel contamination within aluminium foil wrapped products has been
developed. Manufactured by German technology firm Sartorius, the
product, called the Observer, promises...
Filtration specialist Millipore has reported strong growth in sales
in the fourth quarter of 2003, suggesting that the fortunes of the
biopharmaceutical industry - Millipore's primary customer - may be
on the up.